Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation
Repurposing has become a durable component of pharmaceutical innovation, enabling faster clinical deployment of validated mechanisms across disease domains. These findings highlight its potential to expand treatment options while reducing R&D uncertainty.
Authors
- Sanae Akodad (ORCID: https://orcid.org/0009-0006-6221-4794)
- Xixian Niu
- Hilde Stevens
- Berta Secades
Institutions
- Université Libre de Bruxelles (BE)
- International Solvay Institutes (BE)
Publication Details
- Journal
- Communications Medicine
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1038/s43856-025-01344-1
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00